Bepotastine besilate

DRUG7 trials

Conditions

AtopicConjunctivitis, AllergicDermatitisOcular ComfortOcular SurfacePerennial Allergic RhinitisSafetySeasonal Allergic Rhinitis

Phase 1

Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+

CompletedNCT04693429

Laboratorios Sophia S.A de C.V.Ocular Comfort, Ocular Surface, Safety +1

Start: 2020-09-24End: 2020-12-08Updated: 2025-07-16

Phase 2

Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic Conjunctivitis

CompletedNCT00424398

Bausch & Lomb IncorporatedConjunctivitis, Allergic

Start: 2007-02-28Updated: 2013-02-15

Bepotastine Besilate Nasal Sprays in the Treatment of Seasonal Allergic Rhinitis (SAR)

CompletedNCT01753739

Bausch & Lomb IncorporatedSeasonal Allergic Rhinitis

Start: 2013-01-31End: 2013-05-31Updated: 2020-10-05

Phase 3

A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic Dermatitis

CompletedNCT01840605

Tanabe Pharma CorporationAtopic, Dermatitis

Start: 2013-03-31End: 2013-11-30Updated: 2026-01-08

The Confirmatory Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

CompletedNCT01861522

Tanabe Pharma CorporationPerennial Allergic Rhinitis

Start: 2013-04-30End: 2013-12-31Updated: 2026-01-08

A Long-Term Study of TAU-284 in Pediatric Patients With Perennial Allergic Rhinitis

CompletedNCT01900054

Tanabe Pharma CorporationPerennial Allergic Rhinitis

Start: 2013-06-30End: 2013-11-30Updated: 2026-01-07

Unknown Phase

Efficacy of bepotastine besilate for seasonal allergic rhinitis patients - about laryngeal symptoms, olfactory disorder, sleep disorder, QOL and symptoms caused by Asian sand dust

Active, not recruitingJPRN-UMIN000013625

Fujita Health UniversitySeasonal allergic rhinitis

Start: 2014-01-15Target: 50Updated: 2025-07-18

Related Papers

Double-blind placebo-controlled study of bepotastine besilate in pediatric patients with perennial allergic rhinitis

Expert Opinion on Pharmacotherapy2015-09-129 citations

Integrated phase III trials of bepotastine besilate ophthalmic solution 1.5% for ocular itching associated with allergic conjunctivitis.

2012-05-016 citations

Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.

2009-09-0127 citations